Oncology

Long-term survival results after 5 years of ipilimumab therapy in patients with advanced melanoma shows promise.

Novel oral soluble film is indicated to prevent highly and moderately emetogenic chemotherapy-induced nausea and vomiting.

Toradol may limit ability of tumor cells to grow and spread.

Toxin may inhibit cell division in cancerous cells.

Results of the long-awaited Keynote 006 study prove the superiority of pembrolizumab to ipilimumab on criteria of both progression-free survival and overall survival.

Destabilized cell metabolism can lead to the creation of tumors.

Contamination with particulate matter can lead to inflammation, allergic reaction, and blood vessel blockage.

Iressa blocks the activity of an enzyme responsible for regulating pathways implicated in the growth and survival of cancer cells.

Heat shock protein inhibitors may stop proteins involved in cancer cell survival.

Particles are surrounded by a protective coating to release drugs in the presence of a specific tumor enzyme.

Pharmacists will need to evaluate several new factors when selecting and dispensing products.

Colonoscopy can catch tumors in a more treatable stage.

Sonidegib treats adult patients with locally advanced basal cell carcinoma that has recurred following surgery or radiation therapy.

Researchers explore potential of sunscreens with cancer-preventive properties.

Silver is a useful element to prevent bacterial growth.

Study finds less than half of cancer patients have a completed will.

Doxorubicin can be safely omitted in treatments for Wilms' tumor patients deemed least likely to relapse.

Targeting protein that helps cancer cells survive chemotherapy shows promise.

Protein may potentially offer a future therapeutic target.

Stopping smoking extends survival by nearly a year.

Treatment improves overall survival.

T cells derived from lymph nodes expanded and activated in a laboratory before being injected back into patients.

Protein AKAP4 identified as the most accurate way to detect non-small cell lung cancer.

Study finds that mitochondria of tumor cells are critical to survival and proliferation.

Pfizer executive discusses the present and future of biosimilars.

Researchers evaluate why early trials of dasatinib did not give conclusive results.

Drug could be less expensive to produce and less harmful to healthy cells.

Drug treats cutaneous manifestations of t-cell lymphoma.